BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

26 related articles for article (PubMed ID: 31075722)

  • 1. Effect of solution focused group therapy on depressive symptoms and cognitive flexibility of depressive disorder patient.
    Duan D; Wang W; Zhang J; Gu Z
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Sept 28; 48(9):1343-1349. PubMed ID: 38044645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of clinical efficacy of oxcarbazepine and lamotrigine combined with escitalopram, and impact on prognostic quality of life in treating patients with epilepsy and depressive disorder.
    Zhang X; Zhao W
    Exp Ther Med; 2020 Dec; 20(6):146. PubMed ID: 33093884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of mirtazapine combined with escitalopram in the treatment of sleep disorders in patients with depression.
    Xie S; Liu Y
    Minerva Surg; 2024 Apr; 79(2):241-243. PubMed ID: 35088982
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy of levetiracetam combined with oxcarbazepine in the treatment of adults with temporal lobe epilepsy and its impact on memory and cognitive function.
    Li Z; Zhao X; Zhang G; Xi C; Yang L
    Am J Transl Res; 2024; 16(3):1009-1017. PubMed ID: 38586112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antidepressants effects of Rhodiola capsule combined with sertraline for major depressive disorder: A randomized double-blind placebo-controlled clinical trial.
    Gao L; Wu C; Liao Y; Wang J
    J Affect Disord; 2020 Mar; 265():99-103. PubMed ID: 32090788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of venlafaxine hydrochloride combined with tandospirone citrate for patients with vascular depression accompanied by somatic symptoms: An open-labeled randomized control trial.
    Chen H; Lin Y; Zhao Z; Lin T; Lin Q; Chen X; Wu W; Zeng G; Wu S; Liu N; Chen H; Chen R; Xiao Y
    CNS Neurosci Ther; 2024 Mar; 30(3):e14650. PubMed ID: 38514905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological targeting of cognitive impairment in depression: recent developments and challenges in human clinical research.
    Colwell MJ; Tagomori H; Chapman S; Gillespie AL; Cowen PJ; Harmer CJ; Murphy SE
    Transl Psychiatry; 2022 Nov; 12(1):484. PubMed ID: 36396622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative Safety and Efficacy of Two Doses of Tandospirone Citrate for Generalized Anxiety Disorder: A Multicenter Randomized Controlled Trial.
    Li Q; Zhang H; Lin G; Shi S; Zhang Y; Ji J; Yang L; Yao J; Wu W
    Neuropsychiatr Dis Treat; 2022; 18():1653-1664. PubMed ID: 35968511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The safety and efficacy of escitalopram and sertraline in post-stroke depression: a randomized controlled trial.
    Yan N; Hu S
    BMC Psychiatry; 2024 May; 24(1):365. PubMed ID: 38750479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients.
    Yevtushenko VY; Belous AI; Yevtushenko YG; Gusinin SE; Buzik OJ; Agibalova TV
    Clin Ther; 2007 Nov; 29(11):2319-32. PubMed ID: 18158074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Escitalopram therapy for major depression and anxiety disorders.
    Baldwin DS; Reines EH; Guiton C; Weiller E
    Ann Pharmacother; 2007 Oct; 41(10):1583-92. PubMed ID: 17848424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A controlled study of the efficacy and safety of tandospirone citrate combined with escitalopram in the treatment of vascular depression: A pilot randomized controlled trial at a single-center in China.
    Chen H; Lin Q; Lin T; Lin Y; Lin X; Chen R; Luo L; Lin F; Xiao Y
    J Psychiatr Res; 2019 Jul; 114():133-140. PubMed ID: 31075722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy and safety of tandospirone in the treatment of patients with anxiety disorder].
    Tao M; Han YJ; Gao JF; Tang WX; Zhu XZ; Tao DH; Zhang P; Zou Y; Chen H; Tao SF
    Zhonghua Yi Xue Za Zhi; 2012 Apr; 92(13):920-3. PubMed ID: 22781535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of tandospirone augmentation in major depressive disorder patients with high anxiety: A multicenter, randomized, parallel-controlled, open-label study.
    Lin J; Su Y; Wang C; Yang F; Xu Y; Yuan Y; Yuan Y; Wang X; Yu X; Si T
    J Psychiatr Res; 2018 Apr; 99():104-110. PubMed ID: 29433063
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.